-+ 0.00%
-+ 0.00%
-+ 0.00%

ALIGOS THERAPEUTICS, INC.: TOPLINE DATA FOR BOTH HBEAG+ AND HBEAG- COHORTS ARE EXPECTED IN LATE Q3 2027

Reuters·11/06/2026 13:00:01

Please log in to view news